Skip to content

BBNX BBNX Accrued Expenses

Accrued Expenses at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$55.7M+10.4%
Medtronic logo
MedtronicMDT
$3.63B-1.3%
AdaptHealth logo
AdaptHealthAHCO
$3.89M-87.3%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$94.6M+230%
Insulet logo
InsuletPODD

Other financials

Income statement

See full
Revenue$27.6M+56.6%
Gross profit$16.4M+83.2%
Operating income-$24.3M-30.2%
Net income-$21.9M+23.6%
EPS (diluted)-$0.49+47.3%

Balance sheet

See full
Cash & equivalents$30.2M-28.9%
Total debt$6.9M-0.9%
Total equity$271.2M-13.5%
Total assets$304.4M-9.9%

Cash flow

See full
Operating cash flow-$23.8M-19.3%
CapEx$1.4M+314%
Free cash flow-$25.2M-24.1%

Valuation

See full
Market cap$708.98M-8.6%
Enterprise value$685.68M
P/S6.4×

Profitability

See full
Gross margin57.2%+3.2pp
Operating margin-70.1%-6.4pp
Net margin-60.3%-17.4pp
FCF margin-55.4%-14.3pp

Returns & leverage

See full
Return on equity-22.7%
Debt / equity0.0×
Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesAndOtherLiabilities.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BBNX's accrued expenses?
BBNX (BBNX) reported accrued expenses of $17.33M in Q1 2026.
How has BBNX's accrued expenses changed year-over-year?
BBNX's accrued expenses increased by 64.0% year-over-year, from $10.57M to $17.33M.
What is the long-term trend for BBNX's accrued expenses?
Over 2 years (2023 to 2025), BBNX's accrued expenses has grown at a 66.1% compound annual growth rate (CAGR), from $8.13M to $22.43M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.